null

SMILES: Cc1ccncc1-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O

InChI Key: InChIKey=QRBKHAVJURUOIT-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454183   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454183 (US10717708, Example 47 | US11186544, Example 47) Show SMILES Cc1ccncc1-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O Show InChI InChI=1S/C25H23F3N4O2/c1-16-12-13-29-15-21(16)17-4-10-20(11-5-17)32-14-2-3-22(23(32)33)31-24(34)30-19-8-6-18(7-9-19)25(26,27)28/h4-13,15,22H,2-3,14H2,1H3,(H2,30,31,34)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	330	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454183 (US10717708, Example 47 | US11186544, Example 47) Show SMILES Cc1ccncc1-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O Show InChI InChI=1S/C25H23F3N4O2/c1-16-12-13-29-15-21(16)17-4-10-20(11-5-17)32-14-2-3-22(23(32)33)31-24(34)30-19-8-6-18(7-9-19)25(26,27)28/h4-13,15,22H,2-3,14H2,1H3,(H2,30,31,34)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	1.60E+3	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454183 (US10717708, Example 47 | US11186544, Example 47) Show SMILES Cc1ccncc1-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O Show InChI InChI=1S/C25H23F3N4O2/c1-16-12-13-29-15-21(16)17-4-10-20(11-5-17)32-14-2-3-22(23(32)33)31-24(34)30-19-8-6-18(7-9-19)25(26,27)28/h4-13,15,22H,2-3,14H2,1H3,(H2,30,31,34)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	330	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454183 (US10717708, Example 47 | US11186544, Example 47) Show SMILES Cc1ccncc1-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O Show InChI InChI=1S/C25H23F3N4O2/c1-16-12-13-29-15-21(16)17-4-10-20(11-5-17)32-14-2-3-22(23(32)33)31-24(34)30-19-8-6-18(7-9-19)25(26,27)28/h4-13,15,22H,2-3,14H2,1H3,(H2,30,31,34)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.60E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair